Filter
Compound repurposing
Filters
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
5-Methoxysterigmatocystin (HB3727)
Description:Mycotoxin. Derivative of sterigmatocystin.
Purity:>98%
Undecylprodigiosin (HB4119)
Description:Anticancer agent with multiple modes of action
Purity:>93%